21 October 2021 - BEAM Alliance

How the EU Pharmaceutical Strategy could help prevent the next pandemic

Video recordings of BEAM’s Roundtable. Discussion with EC officials and experts on the AMR initiatives of the EU Pharmaceutical Strategy.

27 September 2021 - BEAM Alliance

BEAM Alliance wants HERA to effectively support R&D in antimicrobial resistance

BEAM Alliance welcomes the HERA proposal but urges EU Member States to recognise the importance of early-stage support for Research…

17 November 2021 - BEAM Alliance

20 research, medical and pharmaceutical organizations call on G7 to step up action against antibiotic resistance

20 national and international organisations from academia, healthcare, global health and the pharmaceutical industry appealed today to G7 governments to…

24 November 2021 - BEAM Alliance

AMR: The life of innovative SMEs

WAAW 2021. We take you behind the scenes. This series of comics illustrates the life of SMEs innovating in the…

BEAM News
Member News
Events

Latest news of BEAM Alliance

02 April 2020 - BEAM Alliance

Request for Proposals (RFP) for an Agreement for Performance of Work (APW) to develop an online e-learning course on antimicrobial stewardship

To support the Antimicrobial Stewardship and Awareness (ASA) Unit in the Global Coordination and Partnership on Antimicrobial Resistance (GCP) department…

03 December 2019 - BEAM Alliance

New IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistance

The aim of the IMI Antimicrobial Resistance (AMR) Accelerator is to progress the development of new medicines to treat or…

18 November 2019 - BEAM Alliance

BEAM Alliance is releasing a new position paper on PULL Incentives: ‘Incentivising a sustainable response to the threat of AMR’

Without adequate incentives it is anticipated that in less than 2 years from now, many AMR SMEs will have disappeared…

18 November 2019 - BEAM Alliance

New BEAM Alliance Position Paper calls out stakeholders to rapidly provide market-based solutions supporting SME-driven innovation against antimicrobial resistance

The European BEAM Alliance, representing 72 ‘Biotech companies from Europe innovating in AntiMicrobial resistance research’, today released a position paper…

19 July 2019 - BEAM Alliance

BEAM Alliance: Time to give your feedback on how to characterize antimicrobial activity!

The BEAM Alliance proposed a six-way approach to characterize ATM activity, with the aim of opening new doors in the…

06 June 2019 - BEAM Alliance

Emergency on planet AMR: a vital pipeline to protect

The sooner we come up with practical solutions, the more SMEs (and currently developed products) we can save from vanishing.…

page 3/5

Tweets by alliancebeam

View twitter feed

Latest news of BEAM Members

02 December 2021 - Infex Therapeutics Ltd

Infex scientists achieve breakthrough with potential new drug for Omicron and new coronavirus strains

Infex scientists achieve breakthrough with potential new drug for Omicron and new coronavirus strains. Infex Therapeutics is part of iiCON,…

03 November 2021 - BioVersys AG

BioVersys announces first subjects dosed in additional phase 1 clinical trials of BV100

BioVersys AG, a privately owned clinical stage, multi-asset Swiss pharmaceutical company focusing on research and development of small molecules for…

01 November 2021 - Infex Therapeutics Ltd

Budget’s R&D investment increase must propel action on AMR, says Dr Peter Jackson of Infex Therapeutics

Infex is building a new clinical pipeline of innovative drugs to treat pandemic infections and is creating a portfolio of…

04 October 2021 - Nabriva Therapeutics GmbH

Nabriva Publishes Data Demonstrating the Potent Anti-Inflammatory Properties of XENLETA® (lefamulin)

XENLETA® (lefamulin) is a first-in-class semi-synthetic pleuromutilin antibiotic for systemic administration in humans discovered and developed by the Nabriva Therapeutics…

22 September 2021 - NovaBiotics Ltd

NovaBiotics publishes further data on the mechanism of action of its candidate NM001 therapy (Lynovex) for cystic fibrosis (CF)

NovaBiotics Ltd is a leading clinical-stage biotechnology company focused on leveraging its novel immunology platforms to design and develop first-in-class…

10 September 2021 - AdjuTec Pharma AS

AdjuTec Pharma Strengthens the Patent Portfolio

AdjuTec Pharma is a Company that is dedicated to developing and providing novel antibiotic resistance breakers to the global market.…

page 1/32

Events

07 April 2022

6th AMR Conference

The AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the…

26 January 2022

Human – Animal One Health: At the Confluence of human & veterinary public health

«The One Health Concept: At the confluence of human and veterinary public health» aims to bring together researchers, industrial stakeholders and…

10 January 2022

Biotech Showcase 2022 (In-person & Virtual Event)

Engage with Global investors & Life Sciences Executives! Join us from January 10–12, 2022 in San Francisco, or Join us…

09 December 2021

SCT Virtual Symposium: On the hunt for next generation antimicrobial agents

An exciting two-day symposium entitled: On the hunt for next generation antimicrobial agents. This symposium will bring together some of…

23 November 2021

Phage futures Europe: Translating phage-based applications into clinically and commercially viable therapeutics

Seeing the news that Proteon Pharmaceuticals secured a €21 million investment was an exciting moment. It is another backing in…

19 November 2021

REVIVE Webinar: The roles of different actors in developing new treatments for drug-resistant infections

This World Antimicrobial Awareness Week, GARDP, together with WHO, will be holding an AMR Discussions webinar in which a panel…

17 November 2021

6th Annual Microbiome Connect: Gut Therapeutics

This event is a unique gathering of individuals from academia and industry who are collaborating to advance microbiome science.

15 November 2021

3rd SCI-RSC symposium on antimicrobial drug discovery

Coinciding with WHO’s World Antibiotics Awareness week, this two-day meeting will examine the latest advances in antimicrobial drug discovery from…

25 October 2021

BIO-Europe® 2021 Digital – 27th Annual International Partnering Conference

The international BIO-Europe® 2021 gathering will be held digitally, providing certainty, in this time of insecurity, to execute its pivotal…

page 1/12